High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma: a meta-analysis
J Strehl, U Mey, A Glasmacher, B Djulbegovic… - …, 2003 - haematologica.org
BACKGROUND AND OBJECTIVES: High-dose chemotherapy followed by autologous stem
cell transplantation (HDT/ASCT) has proven to be superior to conventional chemotherapy in …
cell transplantation (HDT/ASCT) has proven to be superior to conventional chemotherapy in …
High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma–results of a comprehensive meta-analysis
BACKGROUND: Randomized controlled trials (RCTs) reported conflicting results on the
impact of high-dose chemotherapy (HDCT) and autologous stem cell transplantation in the …
impact of high-dose chemotherapy (HDCT) and autologous stem cell transplantation in the …
Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian …
M Martelli, F Gherlinzoni, A De Renzo… - Journal of clinical …, 2003 - ascopubs.org
Purpose: To evaluate the role of early intensification with high-dose therapy (HDT) and
autologous stem-cell transplantation (ASCT) as front-line chemotherapy for patients with …
autologous stem-cell transplantation (ASCT) as front-line chemotherapy for patients with …
High‐dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive non‐Hodgkin lymphoma (NHL) in adults
A Greb, J Bohlius, D Schiefer… - Cochrane Database …, 2008 - cochranelibrary.com
Background High‐dose chemotherapy with autologous stem cell support (HDT) has been
proven effective in relapsed aggressive non‐Hodgkin lymphoma (NHL). However …
proven effective in relapsed aggressive non‐Hodgkin lymphoma (NHL). However …
Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non …
RC Baldissera, M Nucci, AC Vigorito, A Maiolino… - Acta …, 2006 - karger.com
This prospective multicenter randomized trial compares conventional with early
intensification with high-dose sequential chemotherapy (HDS) and autologous stem cell …
intensification with high-dose sequential chemotherapy (HDS) and autologous stem cell …
[HTML][HTML] High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results …
A Josting, M Sieniawski, JP Glossmann, O Staak… - Annals of oncology, 2005 - Elsevier
Background: Combination chemotherapy can cure patients with non-Hodgkin's lymphoma
(NHL), but those who suffer treatment failure or relapse still have a poor prognosis. High …
(NHL), but those who suffer treatment failure or relapse still have a poor prognosis. High …
Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk …
GW van Imhoff, B van der Holt… - Journal of clinical …, 2005 - ascopubs.org
Purpose Timing, appropriate amount, and composition of treatment before high-dose
therapy and autologous stem-cell transplantation (ASCT) in patients with poor-risk …
therapy and autologous stem-cell transplantation (ASCT) in patients with poor-risk …
Autologous hematopoietic stem cell transplantation in intermediate and high grade non-Hodgkin's lymphoma: a review
C Gisselbrecht, A Bosly, E Lepage, F Reyes, T Philip… - Annals of oncology, 1993 - Elsevier
High dose therapy with or without hematopoietic stem cell rescue has been widely used in
the past decade for treating aggressive Non-Hodgkin's lymphoma. Recent data in high and …
the past decade for treating aggressive Non-Hodgkin's lymphoma. Recent data in high and …
Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: The European Bone Marrow Transplant Group experience
Background Influenced by successful results treating intermediate-and high-grade non-
Hodgkin's lymphoma (NHL), high-dose therapy followed by autologous bone marrow …
Hodgkin's lymphoma (NHL), high-dose therapy followed by autologous bone marrow …
[PDF][PDF] International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas: report of the …
MA Shipp, MD Abeloff, KH Antman… - Journal of Clinical …, 1999 - researchgate.net
Hematopoietic Stem Cell Transplantation in Malignancies was held in Lyon, France. 1 At
that time, there were insufficient data to determine whether high-dose chemotherapy with …
that time, there were insufficient data to determine whether high-dose chemotherapy with …